G Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.31B

+4.74%

0.935

+2.77%

1.30B

+6.61%

0.909

+8.25%

1.34B

+6.9%

0.942

+7.09%

Estimates Revision

The market is revising Upward the revenue expectations for Genpact Limited (G) for FY2025, with the revenue forecasts being adjusted by 0.85% over the past three months. During the same period, the stock price has changed by 17.12%.

Revenue Estimates for FY2025

Revise Upward

+0.85%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.03%

In Past 3 Month

Stock Price

Go Up

+17.12%

In Past 3 Month

6 Analyst Rating

Wall Street analysts forecast G stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for G is 50.00 USD with a low forecast of 43.00 USD and a high forecast of 55.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

3 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

43.00

Averages

50.00

High

55.00

Current: 0.000

Low

43.00

Averages

50.00

High

55.00

UBS

Sell

Buy

upgrade

2025-12-17

Reason

UBS

Price Target

2025-12-17

upgrade

Sell

Buy

Reason

UBS upgraded Generali to Buy from Sell with a price target of EUR 40, up from EUR 23.70. The firm says the company's favorable business mix and capital strength will drive peer-leading earnings growth at an attractive share valuation.

Susquehanna

Neutral

initiated

$50

2025-12-12

Reason

Susquehanna

Price Target

$50

2025-12-12

initiated

Neutral

Reason

Susquehanna initiated coverage of Genpact with a Neutral rating and $50 price target.

BMO Capital

Market Perform

maintain

$49 -> $48

2025-11-07

Reason

BMO Capital

Price Target

$49 -> $48

2025-11-07

maintain

Market Perform

Reason

BMO Capital lowered the firm's price target on Genpact to $48 from $49 and keeps a Market Perform rating on the shares. The company delivered a solid September quarter highlighted by exceeding the high-end of the revenue guidance range, margin expansion, and raised FY25 revenue guide, the analyst tells investors in a research note. Genpact shared that demand signals remain strong, including pipeline strength and agentic solution adoption, the firm added.

Citi

Neutral

initiated

$43

2025-10-22

Reason

Citi

Price Target

$43

2025-10-22

initiated

Neutral

Reason

Citi initiated coverage of Genpact with a Neutral rating and $43 price target. The firm likes the company's diversification efforts but is concerned about its demand environment.

JPMorgan

Neutral

downgrade

$55 -> $50

2025-08-20

Reason

JPMorgan

Price Target

$55 -> $50

2025-08-20

downgrade

Neutral

Reason

JPMorgan lowered the firm's price target on Genpact to $50 from $55 and keeps a Neutral rating on the shares. The firm updated targets in IT services post the Q2 reports, saying the sector is in the third straight year of below-average revenue growth. An improvement in growth is needed to drive higher valuation multiples, the analyst tells investors in a research note. JPMorgan is optimistic that sector growth will improve.

Needham

Mayank Tandon

Buy

maintain

$50 -> $53

2025-08-08

Reason

Needham

Mayank Tandon

Price Target

$50 -> $53

2025-08-08

maintain

Buy

Reason

Needham analyst Mayank Tandon raised the firm's price target on Genpact to $53 from $50 and keeps a Buy rating on the shares. The company posted solid Q2 results, beating estimates on all fronts, given broad-based demand improvement through the quarter, especially for Genpact's AI-based solutions, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Genpact Ltd (G.N) is 11.98, compared to its 5-year average forward P/E of 14.60. For a more detailed relative valuation and DCF analysis to assess Genpact Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

14.60

Current PE

11.98

Overvalued PE

17.88

Undervalued PE

11.31

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

10.30

Current EV/EBITDA

8.53

Overvalued EV/EBITDA

12.13

Undervalued EV/EBITDA

8.47

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.69

Current PS

1.49

Overvalued PS

2.01

Undervalued PS

1.38

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 805.73% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

G News & Events

Events Timeline

No data

News

9.5

01-07PRnewswire

PinnedGenpact Schedules Q4 2025 Earnings Release and Conference Call on February 5, 2026

6.5

2025-12-17NASDAQ.COM

Reasons for Investors to Hold onto H&R Block Stock at This Time

6.5

2025-12-15NASDAQ.COM

Zacks Market Edge Spotlights: NVIDIA, Newmont, Atlassian, Genpact, and Zoom Communications

People Also Watch

Frequently Asked Questions

What is Genpact Ltd (G) stock price today?

The current price of G is 47.62 USD — it has increased 0.46 % in the last trading day.

What is Genpact Ltd (G)'s business?

Genpact Limited is an agentic and advanced technology solutions company. The Company leverages process intelligence and artificial intelligence to deliver measurable outcomes. The Company's segments include Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. Its Financial Services segment covers services the Company provides to clients in the banking, capital markets and insurance sectors. Its core operations services for these clients include customer onboarding, customer service, collections, and others. Its Consumer and Healthcare segment covers services it provides to clients in the consumer goods, retail, life sciences and healthcare sectors. The core operations services it provides to these clients include demand generation, sensing and planning, supply chain planning and management, and others. The Company's High Tech and Manufacturing segment covers services it provides to clients in the high-tech hardware, high-tech software and manufacturing sectors.

What is the price predicton of G Stock?

What is Genpact Ltd (G)'s revenue for the last quarter?

Genpact Ltd revenue for the last quarter amounts to 1.29B USD, increased 6.63 % YoY.

What is Genpact Ltd (G)'s earnings per share (EPS) for the last quarter?

Genpact Ltd. EPS for the last quarter amounts to 0.83 USD, increased 12.16 % YoY.

What changes have occurred in the market's expectations for Genpact Ltd (G)'s fundamentals?

How many employees does Genpact Ltd (G). have?

Genpact Ltd (G) has 140000 emplpoyees as of January 08 2026.

What is Genpact Ltd (G) market cap?

Today G has the market capitalization of 8.21B USD.